Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline.

Krebs, Christine; Brill, Esther; Minkova, Lora; Federspiel, Andrea; Kellner-Weldon, Frauke; Wyss, Patric; Teunissen, Charlotte E; van Harten, Argonde C; Seydell-Greenwald, Anna; Klink, Katharina; Züst, Marc A; Brem, Anna-Katharine; Klöppel, Stefan (2023). Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline. Journal of Alzheimer's disease, 93(1), pp. 107-124. IOS Press 10.3233/JAD-221001

[img]
Preview
Text
jad-prepress_jad--1--1-jad221001_jad--1-jad221001.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (631kB) | Preview

BACKGROUND

Preclinical Alzheimer's disease (AD) is one possible cause of subjective cognitive decline (SCD). Normal task performance despite ongoing neurodegeneration is typically considered as neuronal compensation, which is reflected by greater neuronal activity. Compensatory brain activity has been observed in frontal as well as parietal regions in SCD, but data are scarce, especially outside the memory domain.

OBJECTIVE

To investigate potential compensatory activity in SCD. Such compensatory activity is particularly expected in participants where blood-based biomarkers indicated amyloid positivity as this implies preclinical AD.

METHODS

52 participants with SCD (mean age: 71.00±5.70) underwent structural and functional neuroimaging (fMRI), targeting episodic memory and spatial abilities, and a neuropsychological assessment. The estimation of amyloid positivity was based on plasma amyloid-β and phosphorylated tau (pTau181) measures.

RESULTS

Our fMRI analyses of the spatial abilities task did not indicate compensation, with only three voxels exceeding an uncorrected threshold at p <  0.001. This finding was not replicated in a subset of 23 biomarker positive individuals.

CONCLUSION

Our results do not provide conclusive evidence for compensatory brain activity in SCD. It is possible that neuronal compensation does not manifest at such an early stage as SCD. Alternatively, it is possible that our sample size was too small or that compensatory activity may be too heterogeneous to be detected by group-level statistics. Interventions based on the individual fMRI signal should therefore be explored.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Geriatric Psychiatry and Psychotherapy
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy
04 Faculty of Medicine > University Psychiatric Services > University Hospital of Psychiatry and Psychotherapy > Translational Research Center

Graduate School:

Graduate School for Health Sciences (GHS)

UniBE Contributor:

Krebs, Christine Renate, Brill, Esther, Minkova, Lora Guintcheva, Federspiel, Andrea, Wyss, Patric, Klink, Katharina, Züst, Marc, Brem, Anna- Katharine, Klöppel, Stefan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1875-8908

Publisher:

IOS Press

Language:

English

Submitter:

Pubmed Import

Date Deposited:

28 Mar 2023 13:11

Last Modified:

14 Aug 2023 10:42

Publisher DOI:

10.3233/JAD-221001

PubMed ID:

36970895

Uncontrolled Keywords:

spatial abilities Blood-based biomarkers episodic memory functional MRI neuronal compensation subjective cognitive decline

BORIS DOI:

10.48350/180768

URI:

https://boris.unibe.ch/id/eprint/180768

Actions (login required)

Edit item Edit item
Provide Feedback